Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment

Journal of Neurology, Neurosurgery, and Psychiatry
A BrückJ O Rinne

Abstract

Early stage patients with Parkinson's disease (PD) show cognitive impairment in frontal lobe functions and memory tests. Hippocampal atrophy is seen in medicated patients with advanced PD. To examine whether prefrontal or hippocampal atrophy are already present in early stage PD, and whether such atrophy is associated with cognitive impairment. Twenty non-medicated, non-demented patients with early stage PD and 22 neurologically healthy age matched controls were studied. All subjects underwent magnetic resonance imaging to study hippocampal and prefrontal atrophy. Atrophy was evaluated by a neuroradiologist using a five point scale. In addition, the patients underwent a neuropsychological test battery sensitive to frontal lobe functions and memory. Patients with PD had atrophy in the right and the left prefrontal cortex. In the right hippocampus, the mean atrophy score was 1.15 in PD and 0.45 in controls. Corresponding figures for the left hippocampus were 1.05 for PD and 0.64 for controls. In PD, the left hippocampus atrophy correlated with verbal memory and prefrontal atrophy correlated with impaired performance in a test measuring vigilance. Non-medicated, non-demented patients with early stage PD show hippocampal and prefro...Continue Reading

Citations

Dec 14, 2011·Archives of Neurology·Daniel WeintraubChristopher M Clark
Jun 20, 2012·Archivum Immunologiae Et Therapiae Experimentalis·Megan M Varnum, Tsuneya Ikezu
Aug 29, 2012·Journal of Neural Transmission·S YerramI Bodis-Wollner
Dec 11, 2008·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Ryszard PodemskiKatarzyna Mazur
Dec 1, 2011·Aging & Mental Health·J H LiuJ Zhang
Nov 24, 2011·Brain : a Journal of Neurology·Daniel WeintraubAndrew Siderowf
Sep 6, 2008·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Jane S SaczynskiLenore J Launer
Apr 28, 2006·Current Opinion in Psychiatry·Uwe Ehrt, Dag Aarsland
Jun 2, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M CotelliA Padovani
Nov 17, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·P BorghammerM M Chakravarty
Sep 30, 2005·Dementia and Geriatric Cognitive Disorders·Katie WiltshireRichard Camicioli
Mar 28, 2009·PloS One·Rita WillemssenChristian Beste
May 5, 2011·Journal of Biomedicine & Biotechnology·Simon C SpanswickRobert J Sutherland
Aug 13, 2013·Neurology Research International·Natalie C PalavraSimon J G Lewis
Jul 7, 2012·Imaging in Medicine·Myria PetrouNicolaas I Bohnen
Jan 11, 2008·AJNR. American Journal of Neuroradiology·C TessaM Mascalchi
Apr 4, 2009·AJNR. American Journal of Neuroradiology·G GattellaroM G Bruzzone
Sep 24, 2015·Expert Review of Neurotherapeutics·Paolina PantchevaCesar V Borlongan
Jan 9, 2016·Neuroscience Letters·Fu-Xiang ChenZhang-Ya Lin
Dec 31, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Gretchen O ReynoldsAlice Cronin-Golomb
Mar 18, 2011·Neural Networks : the Official Journal of the International Neural Network Society·Ahmed A Moustafa, Mark A Gluck
Apr 13, 2010·Toxicology Letters·Julie DeguilStéphanie Pain
Mar 25, 2008·Brain and Cognition·Ellen Poliakoff, James H Smith-Spark
Mar 21, 2007·Neurobiology of Aging·Thomas P BouchardRichard M Camicioli
Oct 8, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Carmen Cristea JanvinDag Aarsland
May 23, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Caroline GurvichOwen B White
Mar 14, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Jennifer G GoldmanLeyla deToledo-Morrell
Apr 5, 2013·Journal of Neuropsychology·Leigh Christopher, Antonio P Strafella
Apr 9, 2013·Journal of Neuropsychology·Patrick S R DavidsonRichard Camicioli
Mar 2, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Gordon W DuncanDavid J Burn
Sep 7, 2013·Journal of Neuropsychology·Celine Souchay, Sarah Jane Smith
Jul 3, 2013·Journal of Neuropsychology·Thomas A ShepherdSimon J Ellis
Sep 1, 2015·Journal of Neurodegenerative Diseases·José Christian Machado XimenesGlauce Socorro de Barros Viana
Feb 19, 2013·Human Brain Mapping·Zhong ZhengNader Pouratian
May 4, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Liana G ApostolovaPaul M Thompson
Mar 13, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Nancy D ChiaravallotiNatalia Ojeda
Jun 5, 2010·Brain Pathology·Lisa C Silbert, Jeffrey Kaye
Jul 21, 2015·Cortex; a Journal Devoted to the Study of the Nervous System and Behavior·Nicola M J EdelstynAndrew R Mayes
Aug 26, 2011·Journal of the Neurological Sciences·Naroa Ibarretxe-BilbaoEduardo Tolosa
Aug 5, 2011·Neurobiology of Aging·Liana ApostolovaMona K Beyer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.